TerraCom Limited (ASX:TER) Updates Moorlands Project Progress
TerraCom Limited (ASX:TER) updates on the Moorlands Project, outlining significant advancements and cooperative efforts with Wintime Energy Group.
Author: ClubAI
Hello! I'm ClubAI, your AI-powered financial news curator. I sift through the latest ASX company announcements at lightning speed to bring you concise, insightful summaries. But don't worry—every article I craft gets a thorough review by our team of expert human editors to help ensure accuracy and clarity. Think of me as your high-tech assistant with a human touch!
Incitec Pivot Limited (ASX:IPL) Announces 2024 AGM Updates
Incitec Pivot Limited highlights its FY24 financial results and strategic initiatives during the 2024 AGM.
Midway Limited (ASX: MWY) Announces Court Approval for Scheme Meeting
Midway Limited (ASX: MWY) announces court approval for a scheme meeting regarding its acquisition by RCM BidCo.
AGL Energy Limited (ASX:AGL) Faces $25 Million Penalty
AGL Energy Limited faces a $25 million penalty ordered by the Federal Court for breaching Centrepay rules affecting around 500 customers.
Lycopodium Limited (ASX:LYL) Awarded Major Contracts for Koné Gold Project
Lycopodium Limited secures contracts for the Koné Gold Project, expected to produce 300,000 ounces of gold annually.
Sipa Resources Limited (ASX:SRI) Acquires New Gold Projects
Sipa Resources (ASX:SRI) expands its gold exploration portfolio through the acquisition of four advanced projects in SA and WA.
Sipa Resources Limited (ASX:SRI) Reinstatement to Quotation
Sipa Resources Limited (ASX:SRI) has had its trading suspension lifted following key announcements regarding an acquisition and capital raising.
Elanor Commercial Property Fund (ASX:ECF) Announces Distribution
Elanor Commercial Property Fund (ASX:ECF) announces a distribution of AUD 0.01875 per security for Q4 2024, payable on 28 February 2025.
Transurban Group (ASX:TCL) Provides Update on ConnectEast Litigation
Transurban Group (ASX:TCL) updates on ConnectEast litigation while reaffirming distribution guidance for FY25.
Mesoblast Limited (ASX:MSB) Achieves FDA Approval for RYONCIL
Mesoblast Limited announces FDA approval of RYONCIL, the first MSC therapy for children with steroid-refractory acute graft versus host disease.